Some recent analyst ratings include

• 10/18/2019-
  Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gets downgraded to Market Perform by Svb Leerink with a price target of $6.30
• 10/18/2019-
  Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gets downgraded to Market Perform by Leerink Swann
• 5/3/2019-
  Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gets downgraded to Underweight by Barclays with a price target of $2.50
• 3/7/2019-
  Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) had its Outperform rating reiterated by William Blair
• 2/8/2018-
  Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has coverage initiated with a Neutral ➝ Neutral rating and $3.50 price target

• On 11/20/2017 & Johnson Johnson, Major Shareholder, sold 18,367,346 with an average share price of $2.75 per share and the total transaction amounting to $50,510,201.50.
• On 12/22/2016 Jason S Fisherman, Director, bought 10,000 with an average share price of $3.96 per share and the total transaction amounting to $39,600.00.
• On 12/5/2016 Mary Kay Fenton, CFO, bought 2,500 with an average share price of $4.11 per share and the total transaction amounting to $10,275.00.
• On 12/2/2016 Joel C Barrish, Insider, bought 2,500 with an average share price of $4.06 per share and the total transaction amounting to $10,150.00.
• On 12/30/2015 David Apelian, insider, sold 10,000 with an average share price of $10.50 per share and the total transaction amounting to $105,000.00.
• On 12/28/2015 Mary Kay Fenton, CFO, sold 43,500 with an average share price of $10.08 per share and the total transaction amounting to $438,480.00.
• On 11/11/2015 Nicole Vitullo, Director, sold 550,000 with an average share price of $10.17 per share and the total transaction amounting to $5,593,500.00.

Recent Trading Activity for